Anika Therapeutics, Inc. (NASDAQ: ANIK) CEO gets 12,840 shares via RSUs
Rhea-AI Filing Summary
Anika Therapeutics, Inc. President and CEO Stephen D. Griffin reported the vesting of 12,840 restricted stock units on June 3, 2026, which converted into 12,840 shares of common stock at no cash cost as the second of three equal annual installments from a 38,520-RSU grant awarded on June 3, 2024.
To satisfy tax withholding obligations on this vesting, the issuer retained 3,769 shares at $14.41 per share. After these transactions, Griffin directly holds 45,973 shares of Anika common stock, including 739 shares acquired on May 14, 2026 under the company’s Employee Stock Purchase Plan.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 9,071 shares
Net Buy
3 txns
Insider
Griffin Stephen D.
Role
President and CEO
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Unit | 12,840 | $0.00 | $0.00 |
| Exercise | Common Stock | 12,840 | $0.00 | $0.00 |
| Exercise Price or Tax Liability | Common Stock | 3,769 | $14.41 | $54K |
Holdings After Transaction:
Restricted Stock Unit — 12,840 shares (Direct);
Common Stock — 45,973 shares (Direct)
Footnotes (4)
- F1. Each restricted stock unit ("RSU") represents the contingent right to receive one share of Issuer common stock.
- F2. Includes 739 shares acquired on May 14, 2026 under the Anika Therapeutics, Inc. Employee Stock Purchase Plan.
- F3. Reflects an aggregate of 3,769 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to RSUs that vested on June 3, 2026.
- F4. On June 3, 2024, the Reporting Person was granted 38,520 RSUs vesting in three equal annual installments beginning on June 3, 2025. This transaction reflects the second vesting installment of such RSU award.
Key Figures
RSUs vested and converted: 12,840 shares
Tax withholding shares: 3,769 shares
Tax withholding price: $14.41 per share
+3 more
6 metrics
RSUs vested and converted
12,840 shares
Restricted stock units vested and converted to common stock on June 3, 2026
Tax withholding shares
3,769 shares
Shares retained by issuer to satisfy tax withholding on June 3, 2026 RSU vesting
Tax withholding price
$14.41 per share
Per-share value used when 3,769 shares were retained for tax obligations
RSU grant size
38,520 RSUs
Grant awarded on June 3, 2024, vesting in three equal annual installments
Post-transaction holdings
45,973 shares
Direct common stock holdings of Stephen D. Griffin after the June 3, 2026 transactions
ESPP shares
739 shares
Shares acquired on May 14, 2026 under the Employee Stock Purchase Plan
Key Terms
Restricted Stock Unit, tax withholding obligations, Employee Stock Purchase Plan, derivative security
4 terms
Restricted Stock Unit financial
"Each restricted stock unit represents the contingent right to receive one share"
A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.
tax withholding obligations financial
"shares of common stock retained by the Issuer to satisfy tax withholding obligations"
Employee Stock Purchase Plan financial
"Includes 739 shares acquired on May 14, 2026 under the Employee Stock Purchase Plan"
An employee stock purchase plan is a company program that lets workers buy shares through small payroll deductions, often at a discount to the market price and after a set offering period. Think of it like a workplace savings plan that turns into ownership: it encourages employees to share in the company’s success and can create predictable buying or selling of stock that investors watch because it affects supply, demand and employee incentives.
derivative security financial
"Exercise or conversion of derivative security"
A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What RSU transaction did Anika Therapeutics (ANIK) CEO Stephen D. Griffin report?
Stephen D. Griffin reported the vesting and conversion of 12,840 RSUs into 12,840 shares of Anika common stock on June 3, 2026. This represented the second annual installment of a 38,520-RSU grant awarded on June 3, 2024.
What RSU grant schedule led to the June 3, 2026 vesting for ANIK’s CEO?
On June 3, 2024, Griffin received a grant of 38,520 RSUs, vesting in three equal annual installments starting June 3, 2025. The June 3, 2026 event reflects the second installment of 12,840 RSUs under that grant.
Were the ANIK CEO’s June 3, 2026 transactions open-market purchases or sales?
No. The filing shows RSU conversion (code M) into 12,840 shares and a tax-withholding disposition (code F) of 3,769 shares. There are no open-market purchase (P) or sale (S) transaction codes reported in this Form 4.